📌 Key Takeaways
- Topic: Silica as a Thixotropic Agent: Mechanism, Dosage and Applications
- Keywords: silica distributor
- Published: 2026-11-20 09:58:31
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica for Wafer Polishing: Slurry Types, Particle Size and Performance
- Silica as a Toothpaste Abrasive: How It Cleans and How RDA Is Controlled
- Chambers, H. F. & DeLeo, F. R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629-641 (2009). Article CAS PubMed Central PubMed Google Scholar
- Silica Fume for Concrete: Dosage, Benefits and How It Improves Strength
- Silica in Makeup Powder: Benefits for Oil Absorption and Blurring Effects
- Best Silica Supplier: How to Choose in 2026 (Checklist and Comparison Criteria)
- Zilony‐Hanin, N. et al. Neuroprotective effect of nerve growth element loaded in porous silicon nanostructures in an Alzheimer's Sickness model and potential delivery to the brain. Small 15, 1904203 (2019). Piece Google Scholar
Is Silicon Dioxide Toxic? Safety of Amorphous vs Crystalline Forms Explained
What is silica (SiO₂)?
Grace Syloid Gao, M., Zeng, J., Liang, K., Zhao, D. & Kong, B. Interfacial assembly of mesoporous silica‐based optical heterostructures for sensing applications. Adv. Funct. Mater. 30, 1906950 (2020). Article CAS Google Scholar
What is the difference between fumed silica and precipitated silica?
quartz sand supplier
What drives silica raw material prices?
silica free flow agent MSNs-based scaffolds can enhance the cell proliferation, migration, adhesion and differentiation in bone tissue engineering. Many studies have systematically investigated and revealed the function of MSNs-based scaffolds in the regulation of cellular functions. 483, 484, 485, 486 Bone defects-involved regenerative mend is challenging to obtain a desired outcome due to the delay of early vascularization and poor osteogenic activity of bone implants. In this regard, researchers have designed a polycaprolactone network containing vascular-like structure, and introduced a nanofibrous gelatin-silica scaffold into it. Dimethyloxalylglycine (DMOG) and peptide-1 (BFP) were then loaded into MSNs, and the differential spatial distribution and sequential release of DMOG and BFP allowed the bioactive scaffold to promote angiogenesis by stimulating the migration of human umbilical vein endothelial cells (HUVECs), the tube formation and the expression of angiogenesis-related genes/proteins (HIF-1α, e-NOS, KDR and VEGF), as well as enhance osteogenesis by upregulating the expression of bone marrow-derived mesenchymal stem cells (BMSCs)-related osteogenic genes (Runx2, Col I, OPN and OCN) and promoting mineral matrix formation. 487 Apart from, Mora-Raimundo et al. reported MSNs as a nanocarrier to deliver SOST small interfering RNA (siRNA) and osteostatin, and the as-designed system could be used for osteoporosis remission via enhancing the bone microarchitecture. 379 Wang et al. designed a biomimetic silica-collagen scaffold via a robust biosilicification tactic, and the silica-collagen scaffold could mimic the distinctive microenvironment of bone extracellular matrix (ECM), resulting in the improvement of mesenchymal stem cell (MSC) recruitment and bone repair. 488 These MSNs-based scaffolds have excellent potential for clinical translation in the treatment of bone defects.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.